Article | June 26, 2023

Annex 1 Compliance Guidelines For Biological Indicator Users

By Crystal Hostler

Stack Of Papers GettyImages-579250076

On August 25, 2023, Annex 1 of The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use becomes effective. The annex specifically covers Manufacture of Sterile Medicinal Products and replaces a previous version of the document which was in place since March 2009. The purpose of the update is “to reflect changes in regulatory and manufacturing environments and to remove ambiguity and inconsistencies and will take account of advances in technologies.” The new version is approximately three-fold longer than its predecessor, much of which is regarding the equipment used in aseptic preparation and processing.

Here, we delve into the crucial topic of Annex 1 and provide valuable insights into its impact on your industry. Gain a deeper understanding of the requirements, guidelines, and best practices for compliance whether you're in pharmaceuticals, healthcare, or any field utilizing biological indicators.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online